The director of The University of Queensland’s Research Computing Centre has been named the iTnews Education Chief Information Officer of the Year.

IMB is home to some of the world’s most influential scientific minds, measured by Thomson Reuters Highly Cited Researchers index. New group leader Professor Grant Montgomery was named in this prestigious index.

The Community for Open Antimicrobial Drug Discovery (CO-ADD) at The University of Queensland’s Institute for Molecular Bioscience (IMB) and the Innovative Medicines Initiative (IMI) ENABLE project have aligned to develop potential new antibiotics against multi-drug resistant bacterial infections.

Protagonist Therapeutics, a spin-out company from IMB, has begun clinical trials with a novel drug candidate being investigated as a potential 'oral targeted therapy' for inflammatory bowel diseases.

The Australian Research Council has awarded five new Future Fellows at The University of Queensland, including IMB's Dr Sonia Henriques whose research has huge potential in reducing global carbon emissions.

The CO-ADD Chemistry Prize is an online competition open to all academic researchers and students worldwide, who can submit an abstract and an optional video on how chemistry can fight the war on superbugs and help find the next antibiotic. Entries close 15 January 2016.

The University of Queensland announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation. Research groups led by Professor Paul Young of the School of Chemistry and Molecular Biosciences, and Professor Matt Cooper at UQ’s Institute for Molecular Bioscience will pursue an innovative global health and development research project, titled Next-gen diagnostics for field-based surveillance of Wolbachia and arboviral infections in wild mosquitoes.

The University of Queensland has teamed up with the Queensland Department of Health to bring researchers and clinicians together to take action against antibiotic resistance.

Research to investigate drug leads for cholesterol, antibiotics for drug-resistant bacteria, cardiovascular development, and inflammation are just some of the innovative projects at UQ’s Institute for Molecular Bioscience (IMB) to receive new funding from the National Health and Medical Research Council (NHMRC).

An initiative to create new and potentially life-changing drugs has taken a step forward at The University of Queensland following an Advance Queensland funding agreement with the Queensland Government. The Queensland Emory Drug Discovery Initiative (QEDDI), to be based at UQ, will translate world-class academic drug discovery into candidates for clinical trials.

Researchers at UQ’s Institute for Molecular Bioscience have received $7 million from the Australian Research Council (ARC) to pursue discoveries in a range of health and agriculture areas. The grants will fund projects to develop biosensors that can talk to smartphones, more efficient algal biofactories, and pain treatments from venom.

Researchers from The University of Queensland have helped identify nearly 1,500 genes associated with ageing that could lead to new health treatments.

Dr Joseph Powell, from UQ’s Institute for Molecular Bioscience (IMB), said the discovery, made by an international team of scientists, could lead to improved prevention and treatment for age-related diseases

Please join us on 17 November 2015 for the screening of the film “RESISTANCE” which looks at the devastating impact of antibiotic resistance and asks “Do we need to save antibiotics to save ourselves?”

Does a doorhandle or a keyboard have more germs? The University of Queensland's Dr Alysha Elliott swabbed people's hands and common workplace surfaces to expose some of the germiest places around the office, as part of Global Handwashing Day (15 October).

Taking medicine in the future could be as simple as eating a sunflower seed or drinking a cup of tea thanks to an award to a University of Queensland researcher.

Professor David Craik, from UQ’s Institute for Molecular Bioscience (IMB), will grow medicines in plants after receiving $1 million from the Clive and Vera Ramaciotti Foundation and trustee Perpetual, which he will share with collaborator Professor Marilyn Anderson from La Trobe University.

Researchers from the Institute for Molecular Bioscience (IMB) have made advances in understanding the cellular processes that occur during wound healing, skin cancer, and inflammatory skin conditions such as psoriasis.

UniQuest, the main technology transfer and commercialisation company of The University of Queensland (UQ), has signed an exclusive worldwide licensing agreement with Organovo Holdings, Inc. (NYSE MKT:ONVO), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3D bioprinting technology, to patent applications relating to methodology for producing kidney cells from induced pluripotent stem cells (iPSCs).

Australian researchers have perfected a method of growing mini-kidneys from stem cells for use in drug screening, disease modelling and cell therapy.

University of Queensland PhD student Zoe Schofield is investigating the link between gut bacteria, diet and the human immune system to reduce inflammatory injury.

The University of Queensland (UQ) has joined a national pilot program to improve the promotion and retention of women in science, technology, engineering, mathematics and medicine (STEMM).